EPCAM and prostate cancer: For instance, overexpressed proteins on the surface of cancer cells, like mesothelin (MSLN) and epithelial cell adhesion molecule (EpCAM) are highly expressed in a variety of cancers like breast cancers, prostate cancers, and gastric carcinoma, suggesting that they might be good candidate as targets of designed CAR-T cell.